Does glycemic control with insulin therapy play a role for critically ill patients in hospital?

Patel, Arpita H.; Pittas, Anastassios G.
March 2006
CMAJ: Canadian Medical Association Journal;3/28/2006, Vol. 174 Issue 7, p917
Academic Journal
Analyzes the significance of glycemic control to critically ill hospital patients. Use of insulin therapy to control hyperglycemia; Overview of studies on the clinical importance of glycemic control; Mechanisms that explain the benefits of insulin therapy and glycemic control in critically ill patients.


Related Articles

  • Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes? Deane, Adam M.; Horowitz, Michael // Diabetes Care;Feb2014, Vol. 37 Issue 2, pe40 

    The authors comment on narratives relating to the use of incretin-based therapy for hospitalized patients with hyperglycemia. They describe the results of their mechanistic studies that evaluated incretin-based therapies in the critically ill. They also emphasize the use of insulin in...

  • Ask the Experts. Byrum, Diane // Critical Care Nurse;Apr2004, Vol. 24 Issue 2, p86 

    Stresses the need to treat hyperglycemia in critically ill patients. Description of hyperglycemia; Impact of hyperglycemia on critically ill patients; Reference to several studies about hyperglycemia.

  • EB67 Evidence-Based Glucose Target Range for Insulin Infusions in Critical Care.  // Critical Care Nurse;Apr2012, Vol. 32 Issue 2, pe39 

    An abstract of the article "Evidence-Based Glucose Target Range for Insulin Infusions in Critical Care," by Tamara Coker and Kimberly Roberts is presented.

  • Positionspapier der ÖDG: Therapie der Hyperglykämie bei erwachsenen, kritisch kranken PatientInnen. Clodi, Martin; Resl, Michael; Abrahamian, Heidemarie; Föger, Bernhard; Weitgasser, Raimund // Wiener Klinische Wochenschrift;Dec2012 Supplement, Vol. 124, p104 

    Hyperglycemia frequently occurs in critically ill patients resulting in major complications like an increased cardiovascular event rate or an increased incidence of infections. Based on the currently available evidence insulin therapy should be initiated in patients with blood glucose levels...

  • Glycaemic control and long-term outcomes following transition from modified intensive insulin therapy to conventional glycaemic control. ORFORD, N. R.; BAILEY, M.; KAUKONEN, K.; ELDERKIN, T.; STOW, E. J.; CATTIGAN, C.; KOTOWICZ, M.; BELLOMO, R. // Anaesthesia & Intensive Care;Mar2014, Vol. 42 Issue 2, p239 

    This retrospective observational cohort study compared glycaemic control and long-term outcomes following transition from a modified intensive insulin therapy (mIIT) regimen to conventional glycaemic control (CGC) in adult patients admitted to a tertiary adult general intensive care unit, during...

  • Stress hyperglycaemia in critically ill patients; Potential role of incretin hormones; a preliminary study. Llompart-Pou, J. A.; Fernández-de-Castillo2, A. G.; Burguera, B.; Pérez-Bárcena, J.; Marsé, P.; Rodríguez-Yago, M.; Barcelo, A.; Raurich, J. M. // Nutricion Hospitalaria;ene/feb2012, Vol. 27 Issue 1, p130 

    Background: Stress hyperglycaemia is common in the intensive care unit (ICU) setting and has been related to a worst outcome. Objective: The objective was to characterize the association of glucoregulatory hormones, mainly incretins, with the levels of glycaemia, and its relationship with...

  • Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Plummer, Mark; Bellomo, Rinaldo; Cousins, Caroline; Annink, Christopher; Sundararajan, Krishnaswamy; Reddi, Benjamin; Raj, John; Chapman, Marianne; Horowitz, Michael; Deane, Adam // Intensive Care Medicine;Jul2014, Vol. 40 Issue 7, p973 

    Purpose: Hyperglycaemia is common in the critically ill. The objectives of this study were to determine the prevalence of critical illness-associated hyperglycaemia (CIAH) and recognised and unrecognised diabetes in the critically ill as well as to evaluate the impact of premorbid glycaemia on...

  • Intensive Insulin Therapy in Critical Care Settings. Eastman, Darla Klug; Bottenberg, Michelle M.; Hegge, Karly A.; Ourth, Heather; Kabadi, Udaya // Current Clinical Pharmacology;Jan2009, Vol. 4 Issue 1, p71 

    Hyperglycemia in hospitalized patients has been shown to increase both morbidity and mortality, regardless of the presence of preexisting diabetes. In order to achieve recommended glycemic goals, many patients require the use of intravenous insulin therapy in the critical care setting. Following...

  • Glucose control: how low should you go with the critically ill? Zolotor, Adam J.; Schumann, Sarah-Anne; Vargish, Lisa; Hickner, John // Journal of Family Practice;Aug2009, Vol. 58 Issue 8, p424 

    For hyperglycemic patients admitted to an intensive care unit (ICU), the target blood glucose level should be < or =180 mg/dL, not 81 to 108 mg/dL. More aggressive glucose lowering is associated with a higher mortality rate.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics